Enalaprilat clinical trials
How each study uses Enalaprilat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 9 Feb 1988 · VASOTEC · NDA 019309 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Enalaprilat
- 2
Studies by the year they started
3 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
VA Office of Research and Development (1) · The Hospital for Sick Children (1) · Nova Scotia Health Authority (1)
Related medicines
As reviewed, each with the page that says it.
- One of ACE inhibitors source
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses Enalaprilat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.CompletedNot applicableVA Office of Research and DevelopmentNCT00248807Written as 1.25 mg enalaprilat IV
- Intra-lesional ACE Inhibitor for Treatment of Hypertrophic ScarsWithdrawnPhase 2/3Nova Scotia Health AuthorityNCT05259137Written as Intralesional enalaprilat injection
- The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow DistributionCompletedPhase 3The Hospital for Sick ChildrenNCT00741156Written as Enalaprilat
Codes
What other systems call Enalaprilat · ClinicalTrials.gg INT008499
- MeSH (NLM) D015773EnalaprilatConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) GV0O7ES0R3ENALAPRILAT DIHYDRATEConfirmed FDA, NLM, Wikidata
- RxNorm 3829Confirmed FDA, Wikidata
- Wikidata Q27126932enalaprilat dihydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47510EnalaprilatConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D015773 | Enalaprilat | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | GV0O7ES0R3 | ENALAPRILAT DIHYDRATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3829 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27126932 | enalaprilat dihydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47510 | Enalaprilat | Confirmed FDA, Wikidata |
Also registered as enalaprilat anhydrous (UNII Q508Q118JM · RxNorm 1545989).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.